26 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
12639560	34	Novel N1-(benzyl)cinnamamidine derived NR2B subtype-selective NMDA receptor antagonists.	Merck Sharp & Dohme Research Laboratories
18434149	23	Reactive derivatives for affinity labeling in the ifenprodil site of NMDA receptors.	University of Strasburg
11909726	36	5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition.	Novartis Pharma
20965739	66	Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.	Institut FüR Pharmazeutische Und Medizinische Chemie Der WestfäLischen Wilhelms-UniversitäT MüNster
20875744	6	Synthesis and biological evaluation of radio-iodinated benzimidazoles as SPECT imaging agents for NR2B subtype of NMDA receptor.	Hamamatsu University School of Medicine
20361801	100	Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.	Friedrich-Schiller-Universitat Jena
15225705	19	Oxamides as novel NR2B selective NMDA receptor antagonists.	Gedeon Richter
14552795	13	Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.	Gedeon Richter
31390523	56	Neuroactive Steroid	Sage Therapeutics
30891123	204	1	Janssen Research & Development
29446949	82	Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.	University of Bristol
31351393	17	A novel class of multitarget anti-Alzheimer benzohomoadamantane?chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors.	University of Barcelona
31319263	49	Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.	University of Trieste
26531150	15	Benzo[7]annulene-based GluN2B selective NMDA receptor antagonists: Surprising effect of a nitro group in 2-position.	University Munster
26171651	19	A New Class of Potent N-Methyl-D-Aspartate Receptor Inhibitors: Sulfated Neuroactive Steroids with Lipophilic D-Ring Modifications.	Academy of Sciences of The Czech Republic V.V.I.
21453995	20	Synthesis, evaluation and metabolic studies of radiotracers containing a 4-(4-[18F]-fluorobenzyl)piperidin-1-yl moiety for the PET imaging of NR2B NMDA receptors.	I2Bm
21334205	30	Novel analogues of ketamine and phencyclidine as NMDA receptor antagonists.	Glaxosmithkline Medicines Research Centre
20692832	6	Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approach.	Universit£
17624774	28	Design, synthesis, and biological evaluation of tricyclic heterocycle-tetraamine conjugates as potent NMDA channel blockers.	Chiba University
15056006	69	NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.	Merck Research Laboratories
30103189	21	Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold.	Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
28947933	9	Modulating GluN2B for the Treatment of Neurological and Psychiatric Disorders.	Amri
28797770	13	Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity.	Universit£T M£Nster